$LNSR
LENSAR, Inc.

2022 Q4 Form 10-Q Financial Statement

#000095017022023929 Filed on November 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $10.23M $7.748M $6.987M
YoY Change -8.82% 10.89% 15.07%
Cost Of Revenue $3.750M $3.859M $4.421M
YoY Change -32.94% -12.71% 36.03%
Gross Profit $6.482M $3.889M $3.851M
YoY Change 15.13% 0.99% -1.26%
Gross Profit Margin 63.35% 50.19% 55.12%
Selling, General & Admin $7.204M $6.119M $6.523M
YoY Change 23.97% -6.19% 3.7%
% of Gross Profit 111.14% 157.34% 169.38%
Research & Development $1.615M $1.577M $3.184M
YoY Change -52.81% -50.47% 58.41%
% of Gross Profit 24.92% 40.55% 82.68%
Depreciation & Amortization $853.0K $276.0K $702.0K
YoY Change 10.78% -60.68% 30.0%
% of Gross Profit 13.16% 7.1% 18.23%
Operating Expenses $9.095M $7.696M $10.02M
YoY Change -4.68% -23.16% 16.33%
Operating Profit -$2.613M -$4.083M -$6.165M
YoY Change -33.21% -33.77% 30.89%
Interest Expense $123.0K $92.00K $10.00K
YoY Change 1130.0% 820.0% -84.62%
% of Operating Profit
Other Income/Expense, Net $92.00K $10.00K
YoY Change 820.0%
Pretax Income -$2.490M -$3.991M -$6.155M
YoY Change -36.19% -35.16% 29.31%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.490M -$3.991M -$6.155M
YoY Change -36.19% -35.16% 29.23%
Net Earnings / Revenue -24.34% -51.51% -88.09%
Basic Earnings Per Share -$0.39 -$0.65
Diluted Earnings Per Share -$0.24 -$0.39 -$652.1K
COMMON SHARES
Basic Shares Outstanding 11.02M 11.02M 9.439M
Diluted Shares Outstanding 10.23M 9.439M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.67M $19.29M $32.34M
YoY Change -53.62% -40.35% -24.26%
Cash & Equivalents $14.67M $19.29M $32.34M
Short-Term Investments
Other Short-Term Assets $1.062M $1.302M $1.000M
YoY Change -37.53% 30.2% 35.14%
Inventory $11.74M $7.890M $10.15M
Prepaid Expenses
Receivables $6.040M $3.560M $2.797M
Other Receivables $200.0K $126.0K $369.0K
Total Short-Term Assets $33.72M $32.17M $46.66M
YoY Change -24.76% -31.05% -22.25%
LONG-TERM ASSETS
Property, Plant & Equipment $563.0K $639.0K $1.015M
YoY Change -25.53% -37.04% -73.5%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.685M $2.861M $3.349M
YoY Change -16.49% -14.57% -14.35%
Total Long-Term Assets $22.13M $22.63M $21.44M
YoY Change 2.2% 5.54% 3.58%
TOTAL ASSETS
Total Short-Term Assets $33.72M $32.17M $46.66M
Total Long-Term Assets $22.13M $22.63M $21.44M
Total Assets $55.84M $54.80M $68.10M
YoY Change -15.98% -19.53% -15.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.422M $3.506M $2.399M
YoY Change 101.26% 46.14% 2.09%
Accrued Expenses $4.700M $4.948M $4.204M
YoY Change 2.09% 17.7% 17.1%
Deferred Revenue $768.0K $789.0K $922.0K
YoY Change -15.04% -14.43% 10.29%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $11.42M $9.788M $8.032M
YoY Change 31.06% 21.86% -2.91%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $167.0K $22.00K $90.00K
YoY Change 142.03% -75.56% -97.42%
Total Long-Term Liabilities $167.0K $22.00K $90.00K
YoY Change 142.03% -75.56% -97.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.42M $9.788M $8.032M
Total Long-Term Liabilities $167.0K $22.00K $90.00K
Total Liabilities $13.86M $12.22M $11.06M
YoY Change 19.63% 10.52% -5.99%
SHAREHOLDERS EQUITY
Retained Earnings -$97.51M -$95.02M -$73.69M
YoY Change 25.66% 28.94% 44.03%
Common Stock $139.5M $137.6M $130.7M
YoY Change 5.3% 5.25% 8.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $41.98M $42.58M $57.05M
YoY Change
Total Liabilities & Shareholders Equity $55.84M $54.80M $68.10M
YoY Change -15.98% -19.53% -15.62%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$2.490M -$3.991M -$6.155M
YoY Change -36.19% -35.16% 29.23%
Depreciation, Depletion And Amortization $853.0K $276.0K $702.0K
YoY Change 10.78% -60.68% 30.0%
Cash From Operating Activities -$4.758M -$4.701M -$2.149M
YoY Change 543.84% 118.75% 4198.0%
INVESTING ACTIVITIES
Capital Expenditures $57.00K -$2.000K -$64.00K
YoY Change -136.54% -96.88%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$57.00K -$2.000K -$64.00K
YoY Change -63.46% -96.88% -420.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 196.0K -1.200M 0.000
YoY Change 2.62% -100.0%
NET CHANGE
Cash From Operating Activities -4.758M -4.701M -2.149M
Cash From Investing Activities -57.00K -2.000K -64.00K
Cash From Financing Activities 196.0K -1.200M 0.000
Net Change In Cash -4.619M -5.903M -2.213M
YoY Change 556.11% 166.74% -105.84%
FREE CASH FLOW
Cash From Operating Activities -$4.758M -$4.701M -$2.149M
Capital Expenditures $57.00K -$2.000K -$64.00K
Free Cash Flow -$4.815M -$4.699M -$2.085M
YoY Change 725.9% 125.37% 4070.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3M
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
dei Entity Central Index Key
EntityCentralIndexKey
0001320350
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39473
dei Entity Registrant Name
EntityRegistrantName
LENSAR, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
32-0125724
dei Entity Address Address Line1
EntityAddressAddressLine1
2800 Discovery Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Orlando
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32826
dei City Area Code
CityAreaCode
888
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Local Phone Number
LocalPhoneNumber
536-7271
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
LNSR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11023304
CY2022Q3 us-gaap Revenues
Revenues
7748000
CY2021Q3 us-gaap Revenues
Revenues
8272000
us-gaap Revenues
Revenues
25126000
us-gaap Revenues
Revenues
23237000
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
3859000
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
4421000
us-gaap Cost Of Revenue
CostOfRevenue
11653000
us-gaap Cost Of Revenue
CostOfRevenue
11034000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6119000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6523000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19966000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18076000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1577000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3184000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10199000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8936000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
276000
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
309000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
872000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
931000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4083000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6165000
us-gaap Operating Income Loss
OperatingIncomeLoss
-17564000
us-gaap Operating Income Loss
OperatingIncomeLoss
-15740000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
92000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
10000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
140000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
41000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-3991000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-6155000
us-gaap Net Income Loss
NetIncomeLoss
-17424000
us-gaap Net Income Loss
NetIncomeLoss
-15699000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.65
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.69
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.73
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.73
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.69
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10225000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10225000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9439000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9439000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10089000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10089000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9308000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9308000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19293000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31637000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
31000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
47000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3560000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4638000
CY2022Q3 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
3000
CY2021Q4 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
61000
CY2022Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
126000
CY2021Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
350000
CY2022Q3 us-gaap Inventory Net
InventoryNet
7890000
CY2021Q4 us-gaap Inventory Net
InventoryNet
6488000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1302000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1700000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
32171000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
44813000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
639000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
756000
CY2022Q3 lnsr Equipment Under Lease Net
EquipmentUnderLeaseNet
6732000
CY2021Q4 lnsr Equipment Under Lease Net
EquipmentUnderLeaseNet
6690000
CY2022Q3 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
0
CY2021Q4 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
2000
CY2021Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
121000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
12398000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10870000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2861000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3215000
CY2022Q3 us-gaap Assets
Assets
54801000
CY2021Q4 us-gaap Assets
Assets
66465000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3506000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2694000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4948000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4604000
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
789000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
904000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
526000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
512000
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
19000
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
9788000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8714000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2408000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2803000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
22000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
69000
CY2022Q3 us-gaap Liabilities
Liabilities
12218000
CY2021Q4 us-gaap Liabilities
Liabilities
11586000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11023000
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11023000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10990000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10990000
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
110000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
110000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
137491000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
132363000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-95018000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-77594000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
42583000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
54879000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
54801000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
66465000
us-gaap Profit Loss
ProfitLoss
-17424000
us-gaap Profit Loss
ProfitLoss
-15699000
us-gaap Depreciation
Depreciation
1681000
us-gaap Depreciation
Depreciation
1063000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
872000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
931000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
391000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
388000
lnsr Provision For Doubtful Accounts And Notes Receivable
ProvisionForDoubtfulAccountsAndNotesReceivable
0
lnsr Provision For Doubtful Accounts And Notes Receivable
ProvisionForDoubtfulAccountsAndNotesReceivable
3000
lnsr Gross Inventory Write Down
GrossInventoryWriteDown
173000
lnsr Gross Inventory Write Down
GrossInventoryWriteDown
307000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-11000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
362000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-133000
us-gaap Share Based Compensation
ShareBasedCompensation
4916000
us-gaap Share Based Compensation
ShareBasedCompensation
5323000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1065000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
794000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-398000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-856000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3105000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
271000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
783000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-103000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-95018000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-324000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
221000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
43000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10098000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8230000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
58000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
198000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-58000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-198000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
2400000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
212000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
170000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2188000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
170000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12344000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8258000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
31637000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
40599000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19293000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32341000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
10000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
19000
lnsr Transfer From Inventories To Equipment Under Lease Net
TransferFromInventoriesToEquipmentUnderLeaseNet
1496000
lnsr Transfer From Inventories To Equipment Under Lease Net
TransferFromInventoriesToEquipmentUnderLeaseNet
3285000
lnsr Transfer From Inventories To Property And Equipment Net
TransferFromInventoriesToPropertyAndEquipmentNet
34000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
31000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
54879000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1607000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-6674000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
49812000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
212000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1637000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-6759000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
44902000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1672000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-3991000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
42583000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
67210000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2301000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5182000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
64329000
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
170000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1491000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-4362000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
61628000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1573000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-6155000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
57046000
lnsr Additional Royalty Payments Percentage
AdditionalRoyaltyPaymentsPercentage
0.03
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounting Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed financial statements and accompanying notes to the condensed financial statements. The accounting estimates that require management’s most significant, difficult and subjective judgments include, but are not limited to, revenue recognition and allowance for expected credit losses, the valuation of notes receivable and inventory, the assessment of recoverability of intangible assets and their estimated useful lives, the valuation and recognition of stock-based compensation, operating lease right-of-use assets and liabilities, and the recognition and measurement of current and deferred income tax assets and liabilities. Management evaluates its estimates on an ongoing basis as there are changes in circumstances, facts, and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from these estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The COVID-19 pandemic continues to directly and indirectly impact the Company’s business, results of operations and financial condition, including revenue, expenses, reserves and allowances. The Company continues to monitor developments that are highly uncertain, including supply chain disruptions and price increases, as well as the economic impact on domestic and international suppliers, customers, and markets. The Company assessed certain accounting matters that require consideration of forecasted financial information, including, but not limited to, its current expected credit losses, the carrying value of the Company's intangible assets and other long-lived assets, and valuation allowances in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of September 30, 2022 and through the date of this report. As a result of these assessments, there were no impairments or material increases in expected credit losses or valuation allowances that impacted the Company's condensed financial statements as of and for the three and nine months ended September 30, 2022 and 2021. However, the Company's future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material impacts to the condensed financial statements in future reporting periods.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of the date of issuance of these unaudited condensed interim financial statements, the Company is not aware of any specific event or circumstance that would require the Company to update estimates, judgments or revise the carrying value of any assets or liabilities.</span></p>
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6276000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6987000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20840000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19701000
CY2022Q3 us-gaap Lease Income
LeaseIncome
1472000
CY2021Q3 us-gaap Lease Income
LeaseIncome
1285000
us-gaap Lease Income
LeaseIncome
4286000
us-gaap Lease Income
LeaseIncome
3536000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3560000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4638000
CY2022Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
126000
CY2021Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
350000
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
789000
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
904000
lnsr Accounts Receivables Payment Terms
AccountsReceivablesPaymentTerms
P30D
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
47000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-1000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
17000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
31000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
19000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
9000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
28000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
63000
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-1000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
59000
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
830000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1051000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
814000
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
3000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
18000
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-6000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
0
CY2021Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
12000
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
lnsr Contract With Customer Asset Recognised
ContractWithCustomerAssetRecognised
70000
us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
3000
CY2022Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
67000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
970000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
674000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
784000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
826000
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1009000
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
5200000
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1258000
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2570000
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
812000
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
487000
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
73000
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2467000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4319000
CY2022Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1492000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
173000
CY2022Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
3931000
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1996000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.015
CY2022Q3 us-gaap Inventory Net
InventoryNet
7890000
CY2021Q4 us-gaap Inventory Net
InventoryNet
6488000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1234000
CY2022Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
1472000
CY2021Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
1285000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
4286000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
3536000
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
18762000
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6364000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
12398000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
16362000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5492000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10870000
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P15Y
CY2019Q4 lnsr Contingent Milestone Payments
ContingentMilestonePayments
2400000
CY2019 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P15Y
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
276000
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
309000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
872000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
931000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
277000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.034
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1097000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1165000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1224000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1215000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
6186000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
12398000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3360000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3375000
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
592000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
526000
CY2022Q3 lnsr Accrued Customer Advances
AccruedCustomerAdvances
455000
CY2021Q4 lnsr Accrued Customer Advances
AccruedCustomerAdvances
159000
CY2022Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
12000
CY2021Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
45000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
529000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
499000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4948000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4604000
CY2022Q3 lnsr Contingent Milestone Payments Upon Regulatory Clearance And Commercialization
ContingentMilestonePaymentsUponRegulatoryClearanceAndCommercialization
1200000
lnsr Contingent Milestone Payments Upon Regulatory Clearance And Commercialization
ContingentMilestonePaymentsUponRegulatoryClearanceAndCommercialization
2400000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
us-gaap Common Stock Voting Rights
CommonStockVotingRights
The Company has a single class of common stock in which stockholders are entitled to one vote for each share of common stock
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
CY2022Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
CY2021Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
CY2021Q2 lnsr Maximum Value Of Common And Preferred Stock And Other Securities Issuable
MaximumValueOfCommonAndPreferredStockAndOtherSecuritiesIssuable
100.0
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.69
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.90
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
461
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
2082
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
3161000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y8M12D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.027
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.034
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.008
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.011
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.006
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.011
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.70
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.73
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.70
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.72
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.73
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1672000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1573000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4916000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5323000
CY2022Q3 lnsr Employee Service Share Based Compensation Non Vested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options Future Amortization Remainder Of Fiscal Year
EmployeeServiceShareBasedCompensationNonVestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptionsFutureAmortizationRemainderOfFiscalYear
1649000
CY2022Q3 lnsr Employee Service Share Based Compensation Non Vested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options Future Amortization Next Twelve Months
EmployeeServiceShareBasedCompensationNonVestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptionsFutureAmortizationNextTwelveMonths
4231000
CY2022Q3 lnsr Employee Service Share Based Compensation Non Vested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options Future Amortization Year Two
EmployeeServiceShareBasedCompensationNonVestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptionsFutureAmortizationYearTwo
994000
CY2022Q3 lnsr Employee Service Share Based Compensation Non Vested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options Future Amortization Year Three
EmployeeServiceShareBasedCompensationNonVestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptionsFutureAmortizationYearThree
639000
CY2022Q3 lnsr Employee Service Share Based Compensation Non Vested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options Future Amortization Year Four
EmployeeServiceShareBasedCompensationNonVestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptionsFutureAmortizationYearFour
24000
CY2022Q3 lnsr Employee Service Share Based Compensation Non Vested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options Future Amortization
EmployeeServiceShareBasedCompensationNonVestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptionsFutureAmortization
7537000
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3991000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9308000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6155000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-17424000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-15699000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10225000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10225000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9439000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9439000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10089000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10089000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9308000
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.65
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.73
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.73
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.69
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.69
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2081000
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1746000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2113000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1626000

Files In Submission

Name View Source Status
lnsr-20220930_pre.xml Edgar Link unprocessable
0000950170-22-023929-index-headers.html Edgar Link pending
0000950170-22-023929-index.html Edgar Link pending
0000950170-22-023929.txt Edgar Link pending
0000950170-22-023929-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lnsr-20220930.htm Edgar Link pending
lnsr-20220930.xsd Edgar Link pending
lnsr-ex31_1.htm Edgar Link pending
lnsr-ex31_2.htm Edgar Link pending
lnsr-ex32_1.htm Edgar Link pending
lnsr-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
lnsr-20220930_def.xml Edgar Link unprocessable
lnsr-20220930_lab.xml Edgar Link unprocessable
lnsr-20220930_htm.xml Edgar Link completed
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lnsr-20220930_cal.xml Edgar Link unprocessable